<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> (SSc) is an <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> characterized by multisystem involvement </plain></SENT>
<SENT sid="1" pm="."><plain>Heart involvement occurs in 80-100% of cases and represents one of the more common risk factors of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001685'>Myocardial fibrosis</z:hpo> and vascular <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> lead to <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and impaired contractility with secondary left and right <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Pulmonary arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> in some patients with systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> results in right <z:hpo ids='HP_0001635'>heart failure</z:hpo> and low output syndrome during the end-stage of the disease </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of the present study was to analyze four cases of systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> with severe cardiovascular complications and a fatal outcome </plain></SENT>
<SENT sid="5" pm="."><plain>CASE DESCRIPTIONS: Case 1: A 68-year-old female who probably suffered from limited SSc (lcSSc) and pulmonary arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> for more than 10 years was unsuccessfully treated with vasodilatators (sildenafil, iloprost) </plain></SENT>
<SENT sid="6" pm="."><plain>Case 2: A 52-year-old female with a 5-year history of diffuse cutaneous SSc (dcSSc), <z:hpo ids='HP_0006530'>interstitial lung disease</z:hpo>, and pulmonary arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> underwent aggressive therapy with immunosuppressive and antiproliferative (<z:chebi fb="0" ids="50861">treprostinil</z:chebi>) agents but without effect on the progression of the disease </plain></SENT>
<SENT sid="7" pm="."><plain>Case 3: A 50-year-old male with dcSSc and coexistent <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> with dominating symptoms of right <z:hpo ids='HP_0001635'>heart failure</z:hpo> was placed on high doses of <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi> (i.v </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>) and had a cardioverter-defibrillator implanted as part of primary prevention </plain></SENT>
<SENT sid="9" pm="."><plain>The patient died with symptoms of severe, therapy-resistant, two-sided <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Case 4: A 58-year-old female with a 6-year history of dcSSc, <z:hpo ids='HP_0006530'>interstitial lung disease</z:hpo>, and heart involvement with severe <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and significant mitral and <z:hpo ids='HP_0005180'>tricuspid insufficiency</z:hpo> received intensive immunosuppressive therapy (i.v </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>) and underwent <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> ablation </plain></SENT>
<SENT sid="12" pm="."><plain>Sudden <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> in this patient was attributed to <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> due to <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> associated with systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Lung and heart involvement is the most common reason for poor prognosis in systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="14" pm="."><plain><z:hpo ids='HP_0011675'>Arrhythmias</z:hpo>, usually latent clinically, and right <z:hpo ids='HP_0001635'>heart failure</z:hpo> associated with <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> or <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> are the main reasons of cardiac <z:hpo ids='HP_0011420'>death</z:hpo> in SSc patients </plain></SENT>
<SENT sid="15" pm="."><plain>Severe and fatal cardiovascular complications occur more often in dcSSc, particularly during the first few years after diagnosis </plain></SENT>
<SENT sid="16" pm="."><plain>Early detection of cardiovascular manifestations should be a priority in systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
</text></document>